Thu, Jan 26, 2012 - Page 5 News List

Roche makes ‘unsolicited offer’ for US firm Illumina


Swiss pharmaceuticals giant Roche yesterday announced it had launched a takeover bid for Illumina, a US company that specializes in life sciences.

Roche said it had made “multiple efforts” to start talks with Illumina to negotiate a deal, but the US firm had not been willing to enter “substantive discussions.”

“Roche has therefore decided to promptly commence a tender offer to purchase all of the outstanding shares of common stock of Illumina for US$44.50 per share in cash,” a company statement said.

This offer was “full and fair value” for the company, Roche chief executive Severin Schwan said in a statement.

“It is our strong preference to enter into a negotiated transaction with Illumina, and we remain willing to engage in a constructive dialogue with Illumina to jointly develop an optimal strategy for maximizing the value of our combined business,” Schwan added.


The statement said that the offer represented a 64 percent premium over Illumina’s stock price on Dec. 21 last year and put the value of the San Diego-based company at US$5.7 billion.

A brief statement from Illumina acknowledged that Roche had made an “unsolicited offer” for the company.

It said the board of directors would “thoroughly review” the proposal and make a recommendation “in due course,” adding that it had asked share holders to take no action in the meantime.

This story has been viewed 2860 times.

Comments will be moderated. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned.

TOP top